Cargando…

Alterations in White Matter Evident Before the Onset of Psychosis

BACKGROUND: Psychotic disorders are associated with widespread reductions in white matter (WM) integrity. However, the stage at which these abnormalities first appear and whether they are correlates of psychotic illness, as opposed to an increased vulnerability to psychosis, is unclear. We addressed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carletti, Francesco, Woolley, James B., Bhattacharyya, Sagnik, Perez-Iglesias, Rocio, Fusar Poli, Paolo, Valmaggia, Lucia, Broome, Matthew R., Bramon, Elvira, Johns, Louise, Giampietro, Vincent, Williams, Steve C. R., Barker, Gareth J., McGuire, Philip K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494044/ https://www.ncbi.nlm.nih.gov/pubmed/22472474 http://dx.doi.org/10.1093/schbul/sbs053

Ejemplares similares

Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis
por: Fusar-Poli, Paolo, et al.
Publicado: (2014)

Functional brain networks before the onset of psychosis: A prospective fMRI study with graph theoretical analysis()()
por: Lord, Louis-David, et al.
Publicado: (2012)

Formal thought disorder in people at ultra-high risk of psychosis
por: Demjaha, Arsime, et al.
Publicado: (2017)

Services for people at high risk improve outcomes in patients with first episode psychosis
por: Fusar‐Poli, P., et al.
Publicado: (2015)

The Provision of Education and Employment Support At the Outreach and Support in South London (OASIS) Service for People at Clinical High Risk for Psychosis
por: Tognin, Stefania, et al.
Publicado: (2019)

White matter microstructure in schizophrenia: effects of disorder, duration and medication
por: Kanaan, Richard, et al.
Publicado: (2009)

Neighbourhood deprivation is positively associated with detection of the ultra-high risk (UHR) state for psychosis in South East London
por: Bhavsar, V., et al.
Publicado: (2018)

M136. PSYCHOSIS POLYRISK SCORE (PPS): IMPROVING DETECTION OF INDIVIDUALS AT-RISK AND PREDICTION OF CLINICAL OUTCOMES
por: Oliver, Dominic, et al.
Publicado: (2020)

E-Clinical High Risk for Psychosis: Viewpoint on Potential of Digital Innovations for Preventive Psychiatry
por: Reilly, Thomas, et al.
Publicado: (2019)

Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation
por: Schmidt, André, et al.
Publicado: (2017)

F256. CAN WE REDUCE THE DURATION OF UNTREATED PSYCHOSIS?
por: Oliver, Dominic, et al.
Publicado: (2018)

S126. GOOD OUTCOME IN INDIVIDUALS AT ULTRA-HIGH RISK (UHR) OF DEVELOPING PSYCHOSIS: A DELPHI STUDY
por: Petros, Natalia, et al.
Publicado: (2018)

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
por: Colizzi, Marco, et al.
Publicado: (2019)

Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
por: Appiah-Kusi, E., et al.
Publicado: (2020)

Cannabidiol modulation of hippocampal glutamate in early psychosis
por: O’Neill, Aisling, et al.
Publicado: (2021)

S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE
por: Colizzi, Marco, et al.
Publicado: (2018)

34.2 IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN SECONDARY MENTAL HEALTH CARE
por: Fusar-poli, Paolo, et al.
Publicado: (2018)

Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report
por: Davies, Cathy, et al.
Publicado: (2021)

17.3 EFFECT OF CANNABIDIOL ON SYMPTOMS, DISTRESS AND NEUROPHYSIOLOGICAL ABNORMALITIES IN CLINICAL HIGH-RISK FOR PSYCHOSIS PATIENTS: A PLACEBO-CONTROLLED STUDY
por: Bhattacharyya, Sagnik, et al.
Publicado: (2018)

Mapping the implementation and challenges of clinical services for psychosis prevention in England
por: Estradé, Andrés, et al.
Publicado: (2023)

Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Gender Differences in White Matter Microstructure
por: Kanaan, Richard A., et al.
Publicado: (2012)

Insular volume abnormalities associated with different transition probabilities to psychosis
por: Smieskova, R., et al.
Publicado: (2012)

Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies
por: Oliver, Dominic, et al.
Publicado: (2018)

T109. TRAVERSING THE TRANSDIAGNOSTIC GAP BETWEEN DEPRESSION, MANIA AND PSYCHOSIS WITH NATURAL LANGUAGE PROCESSING
por: Patel, Rashmi, et al.
Publicado: (2020)

Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

T97. REAL WORLD IMPLEMENTATION OF A TRANSDIAGNOSTIC RISK CALCULATOR FOR THE AUTOMATIC DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN CLINICAL ROUTINE
por: Oliver, Dominic, et al.
Publicado: (2020)

Genome-wide discovered psychosis-risk gene ZNF804A impacts on white matter microstructure in health, schizophrenia and bipolar disorder
por: Mallas, Emma-Jane, et al.
Publicado: (2016)

Outreach and support in South-London (OASIS) 2001—2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis
por: Davies, Cathy, et al.
Publicado: (2018)

Real World Implementation of a Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk of Psychosis in Clinical Routine: Study Protocol
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Cannabidiol as a potential treatment for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis
por: Fusar-Poli, Paolo, et al.
Publicado: (2016)

T145. EFFECTS OF CANNABIDIOL ON EMOTION PROCESSING IN PSYCHOSIS RISK: AN FMRI INVESTIGATION
por: Davies, Cathy, et al.
Publicado: (2020)

Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
por: Patel, Rashmi, et al.
Publicado: (2016)

17. CANNABIDIOL AS A TREATMENT IN DIFFERENT STAGES OF PSYCHOSIS- EFFICACY AND MECHANISMS
por: Bhattacharyya, Sagnik
Publicado: (2018)

34. IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS
por: Fusar-poli, Paolo
Publicado: (2018)

Cannabinoids, reward processing, and psychosis
por: Gunasekera, Brandon, et al.
Publicado: (2021)

Early Intervention Services for First Episode of Psychosis in South London and the Maudsley (SLaM): 20 Years of Care and Research for Young People
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

Epigenetic Mediation of AKT1 rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing
por: Blest-Hopley, Grace, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_snpprda3i7rivtj9r2csdjsug1